Funding for this research was provided by:
Nanjing Municipal Health Bureau (ZKX15033)
Ministry of Science and Technology of the People's Republic of China (2016YFC1306805)
General Program of Jiangsu commission of health (H2017051)
Received: 26 August 2019
Accepted: 21 May 2020
First Online: 5 June 2020
Ethics approval and consent to participate
: All research procedures were approved by the Medical Research Ethics Committee of Nanjing Brain Hospital, and were conducted in accordance with the 1964 Helsinki declaration and its later amendments. Written informed consent of the schizophrenic patient was obtained from his/her legally authorized representative and the control provided written informed consent himself/herself after totally understanding the purpose of our study.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.